Sunshine Drugs Limited

sunshinedrugs.com

An independently owned and operated retail pharmacy business; currently totaling seven local pharmacies in Windsor, Ontario (Canada): 1909 IDA, Fontainebleu, Forest Glade IDA, Moy Medical IDA, Sandwich IDA, IDA TLC, and Westminster IDA. Find us on Facebook by keywords "Sunshine Drugs".

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

CATALENT TO ACQUIRE METRICS CONTRACT SERVICES FOR $475 MILLION TO EXPAND HIGH-POTENT CAPABILITIES AND ORAL DEVELOPMENT AND MANUFACTURING CAPACITY

Catalent, Inc. | August 10, 2022

news image

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has reached an agreement to acquire Metrics Contract Services a full-service specialty Contract Development and Manufacturing Organization with a facility in Greenville, North Carolina, for $475 million from Mayne Pharma Group Limited. Upon completion, the acquisition will stre...

Read More

Pharmacy Market

BAUDAX BIO ACQUIRES TERAIMMUNE, INC.

Globenewswire | July 03, 2023

news image

Baudax Bio, Inc. a pharmaceutical company focused on innovative products for acute care and related settings, announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune diseases. “This combination blends the world class scientific expertise of the TeraImmune team with the Baudax team’s proven ability to execute clinical development programs, which we believe ...

Read More

ALLIED EXPANDS PHARMACEUTICAL PIPELINE BY FILING US PROVISIONAL PATENT FOR PSILOCYBIN BASED THERAPEUTICS

Allied Corp | October 21, 2020

news image

Allied Corp, an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues is pleased to announce the filing of a new United States provisional patent application entitled “PSILOCYBIN COMPOSITIONS AND FORMULATIONS AND THEIR USE IN TREATING MENTAL HEALTH DISORDERS AND IMPROVING MENTAL HEALTH”. The provisional patent application covers a novel combination of psilocybin and proprietary mushroom f...

Read More

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

news image

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More
news image

Business Insights

CATALENT TO ACQUIRE METRICS CONTRACT SERVICES FOR $475 MILLION TO EXPAND HIGH-POTENT CAPABILITIES AND ORAL DEVELOPMENT AND MANUFACTURING CAPACITY

Catalent, Inc. | August 10, 2022

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has reached an agreement to acquire Metrics Contract Services a full-service specialty Contract Development and Manufacturing Organization with a facility in Greenville, North Carolina, for $475 million from Mayne Pharma Group Limited. Upon completion, the acquisition will stre...

Read More
news image

Pharmacy Market

BAUDAX BIO ACQUIRES TERAIMMUNE, INC.

Globenewswire | July 03, 2023

Baudax Bio, Inc. a pharmaceutical company focused on innovative products for acute care and related settings, announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune diseases. “This combination blends the world class scientific expertise of the TeraImmune team with the Baudax team’s proven ability to execute clinical development programs, which we believe ...

Read More
news image

ALLIED EXPANDS PHARMACEUTICAL PIPELINE BY FILING US PROVISIONAL PATENT FOR PSILOCYBIN BASED THERAPEUTICS

Allied Corp | October 21, 2020

Allied Corp, an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues is pleased to announce the filing of a new United States provisional patent application entitled “PSILOCYBIN COMPOSITIONS AND FORMULATIONS AND THEIR USE IN TREATING MENTAL HEALTH DISORDERS AND IMPROVING MENTAL HEALTH”. The provisional patent application covers a novel combination of psilocybin and proprietary mushroom f...

Read More
news image

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us